Long-term Use of Intrapulmonary Percussive Ventilation for Preventing Hospitalizations Due to Respiratory Decompensation in Children With Multiple Disabilities

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age1-16
SponsorAssistance Publique - Hôpitaux de Paris

About this trial

Chronic respiratory failure is the leading cause of morbidity and mortality in children with multiple disabilities. Musculoskeletal disorders, swallowing disorders and ventilatory control abnormalities lead to progressive respiratory impairment, causing episodes of respiratory decompensation (RD). These are the leading cause of mortality (50 to 80%, average age of death: 21 years) and the cause of repeated hospitalizations.

Respiratory care for these children is therefore a major challenge. In respiratory physiotherapy, this can be achieved through manual techniques and/or instrumental techniques such as intrapulmonary percussive ventilation (IPV), which is particularly useful in this population because it does not require active cooperation.

The main objective of this study is to evaluate, in children with multiple disabilities, the effectiveness at 18 months of using an IPV at home and by carers, combined with standard respiratory physiotherapy, compared with manual respiratory physiotherapy alone.This is a multicenter, randomized controlled superiority trial with two parallel groups.

All centers will recruit children aged 1 to 16 with multiple disabilities, during hospitalization with respiratory decompensation (RD). After consent has been signed by the parents or legal guardians, the patient will be randomized into one of the two study groups:

* Control group: manual respiratory physiotherapy. * Intervention group: intrapulmonary Percussive Ventilation (IPV)

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Causal brain injury or lesion occurring before the age of 3 years,

Severe or profound intellectual disability according to DSM IV definition

Motor disability: paraplegia/quadriplegia, hemiparesis, ataxia, and/or extrapyramidal motor disorders,

Gross Motor Function Classification System (GMFCS) score of IV or V,

Disqualifiers

Associated neuromuscular disease

Daily use of intrapulmonary percussive ventilation for more than 3 consecutive months within the 6 months prior to inclusion,

Daily use of a cough assistance device such as an insufflator-exsufflator for more than 3 consecutive months within the 6 months prior to inclusion,

Pneumothorax,

Trial design

Design model

Parallel

Treatments tested in this trial

  • Intrapulmonary Percussive Ventilation IPV

    Procedure/Surgery

    After the device has been adjusted to suit the child and carers have been trained during hospitalisation, IPV will be prescribed for use by carers at home for 15 minutes, five times a week, in addition to manual RP prescribed 2 to 3 times a week in private practice or at home.

Treatment groups

146 Participants
are divided into 2 treatment groups
Group A: IPV + Manual Respiratory PhysiotherapyExperimental treatment 1 intervention
Group B: Manual Respiratory Physiotherapy OnlyNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

Number of readmissions with respiratory decompensation

Time frame
18 months after the index hospitalization with respiratory decompensation

Secondary outcomes

1

Number of days of hospitalization

Hospital days with respiratory decompensation in conventional service and in the intensive Care Unit

Time frame
18 months after the index hospitalization with respiratory decompensation.
2

Number and duration of respiratory exacerbations managed at home, emergency visits not followed by hospitalizations and unscheduled consultations

Time frame
18 months after the index hospitalization with respiratory decompensation.
3

Number of days on antibiotics for respiratory issues

Track antibiotic use for respiratory conditions outside of baseline treatment

Time frame
18 months after the index hospitalization with respiratory decompensation.
4

PolyQol scale

change in the child's quality of life using the PolyQol scale

Time frame
At month 1, month 3, month 6, month 12, and month 18

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: